Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6712175rdf:typepubmed:Citationlld:pubmed
pubmed-article:6712175lifeskim:mentionsumls-concept:C0013227lld:lifeskim
pubmed-article:6712175lifeskim:mentionsumls-concept:C1705165lld:lifeskim
pubmed-article:6712175lifeskim:mentionsumls-concept:C0311474lld:lifeskim
pubmed-article:6712175lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:6712175lifeskim:mentionsumls-concept:C2700061lld:lifeskim
pubmed-article:6712175lifeskim:mentionsumls-concept:C0150312lld:lifeskim
pubmed-article:6712175lifeskim:mentionsumls-concept:C0303267lld:lifeskim
pubmed-article:6712175lifeskim:mentionsumls-concept:C0070310lld:lifeskim
pubmed-article:6712175pubmed:issue1-2lld:pubmed
pubmed-article:6712175pubmed:dateCreated1984-5-23lld:pubmed
pubmed-article:6712175pubmed:abstractTextThe influence of an antitumoral drug, the pentaziridinocyclodiphosphatiazene (SOAZ), on the right----left-handed helix conformational transition of Poly (dG-dC). Poly (dG-dC) induced by carcinogenic or mutagenic Nickel compounds has been studied by ultraviolet absorbance and circular dichroïsm measurements. The B----Z transition of the polynucleotide is induced in two steps, in a similar way whatever the origin of the Nickel ions (NiCl2, NiSO4, Ni3S2, NiCO3). The midpoint of the second step (right----left-transition) is located around 0.4 mM Ni2+. The addition of SOAZ to the Poly (dG-dC). Poly (dG-dC) modifies this transition which is shifted to 2 mM Ni2+ for a 1 SOAZ/10 DNA phosphates ratio. The right-handed helix is stabilized and for a 1.5 SOAZ/phosphate ratio no B----Z transition is observed even for a tenfold amount of added Nickel (4 mM Ni2+). The addition of SOAZ to the DNA initially converted to a Z conformation by the presence of Nickel inhibits the return to the B form.lld:pubmed
pubmed-article:6712175pubmed:languageenglld:pubmed
pubmed-article:6712175pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6712175pubmed:citationSubsetIMlld:pubmed
pubmed-article:6712175pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6712175pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6712175pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6712175pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6712175pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6712175pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6712175pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6712175pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6712175pubmed:statusMEDLINElld:pubmed
pubmed-article:6712175pubmed:issn0250-7005lld:pubmed
pubmed-article:6712175pubmed:authorpubmed-author:LiquierJJlld:pubmed
pubmed-article:6712175pubmed:authorpubmed-author:TaillandierEElld:pubmed
pubmed-article:6712175pubmed:authorpubmed-author:LabarreJ FJFlld:pubmed
pubmed-article:6712175pubmed:authorpubmed-author:SourniesFFlld:pubmed
pubmed-article:6712175pubmed:authorpubmed-author:BourtayrePPlld:pubmed
pubmed-article:6712175pubmed:authorpubmed-author:PizzorniLLlld:pubmed
pubmed-article:6712175pubmed:issnTypePrintlld:pubmed
pubmed-article:6712175pubmed:volume4lld:pubmed
pubmed-article:6712175pubmed:ownerNLMlld:pubmed
pubmed-article:6712175pubmed:authorsCompleteYlld:pubmed
pubmed-article:6712175pubmed:pagination41-4lld:pubmed
pubmed-article:6712175pubmed:dateRevised2000-12-18lld:pubmed
pubmed-article:6712175pubmed:meshHeadingpubmed-meshheading:6712175-...lld:pubmed
pubmed-article:6712175pubmed:meshHeadingpubmed-meshheading:6712175-...lld:pubmed
pubmed-article:6712175pubmed:meshHeadingpubmed-meshheading:6712175-...lld:pubmed
pubmed-article:6712175pubmed:meshHeadingpubmed-meshheading:6712175-...lld:pubmed
pubmed-article:6712175pubmed:meshHeadingpubmed-meshheading:6712175-...lld:pubmed
pubmed-article:6712175pubmed:meshHeadingpubmed-meshheading:6712175-...lld:pubmed
pubmed-article:6712175pubmed:meshHeadingpubmed-meshheading:6712175-...lld:pubmed
pubmed-article:6712175pubmed:meshHeadingpubmed-meshheading:6712175-...lld:pubmed
pubmed-article:6712175pubmed:meshHeadingpubmed-meshheading:6712175-...lld:pubmed
pubmed-article:6712175pubmed:articleTitleSpectroscopic studies of conformational transitions in double stranded DNAs in the presence of carcinogenic nickel compounds and an antitumoral drug (SOAZ).lld:pubmed
pubmed-article:6712175pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6712175lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6712175lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6712175lld:pubmed